A combination of 7-ketocholesterol, lysosphingomyelin and bile acid-408 to diagnose Niemann-Pick disease type C using LC-MS/MS
Open Access
- 8 September 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (9), e0238624
- https://doi.org/10.1371/journal.pone.0238624
Abstract
Niemann-Pick disease type C (NPC) is an autosomal recessive disorder caused by mutations of NPC1 or NPC2, which encode the proteins that are responsible for intracellular cholesterol trafficking. Loss of this function results in the accumulation of cholesterol-related products, such as oxysterols, sphingolipids, and NPC-related bile acids, which were recently used as biochemical biomarkers for the diagnosis of NPC. Bile acid-408 is a new significant compound we found in Japanese NPC patients, and it likely belongs to the category of bile acids. However, the diagnosis of NPC using a single biomarker is not satisfactory for clinical application because of the high instance of false negatives or positives. Therefore, we proposed an application of NPC diagnosis using a combination of 7-ketocholesterol (7-KC), lysosphingomyelin (lysoSM), bile acid-408 and/or glucosylsphingosine (lysoGL-1). 7-KC, lysoSM and lysoGL-1 in sera and bile acid-408 in dried blood spots (DBS) were quantified within 17 minutes using tandem mass spectrometry and high-resolution mass spectrometry, respectively. We measured these biomarkers in NPC patients (n = 19), X-linked adrenoleukodystrophy (X-ALD) patients (n = 5), patients with other lysosomal diseases (n = 300), newborns (n = 124) and healthy people (n = 74). Our results showed a promising accuracy (97%) for NPC diagnosis using the combination of 7-KC, lysoSM and bile acid-408. However, contrary to our expectations, lysoGL-1 levels did not present at a significantly greater amount in NPC patients than other patients and negative controls. The combination of 7-KC, lysoSM and bile acid-408 improves the accuracy of NPC diagnosis and is feasible for mass screening due to its simple sample preparation and measurement. Future research should investigate the chemical structure of bile acid-408 to further facilitate its advantage in diagnosis.Keywords
This publication has 35 references indexed in Scilit:
- Diagnostic tests for Niemann-Pick disease type C (NP-C): A critical reviewMolecular Genetics and Metabolism, 2016
- High incidence of unrecognized visceral/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data setsGenetics in Medicine, 2015
- Diagnosis of Niemann-Pick disease type C with 7-ketocholesterol screening followed by NPC1/NPC2 gene mutation confirmation in Chinese patientsOrphanet Journal of Rare Diseases, 2014
- Niemann-Pick disease type C clinical database: cognitive and coordination deficits are early disease indicatorsOrphanet Journal of Rare Diseases, 2013
- Recommendations for the diagnosis and management of Niemann–Pick disease type C: An updateMolecular Genetics and Metabolism, 2012
- Niemann-Pick disease type COrphanet Journal of Rare Diseases, 2010
- Defective cholesterol trafficking in Niemann‐Pick C‐deficient cellsFEBS Letters, 2010
- Linear clinical progression, independent of age of onset, in Niemann–Pick disease, type CNeuropsychiatric Genetics, Part B of the American Journal of Medical Genetics (AJMG), 2009
- Miglustat for treatment of Niemann-Pick C disease: a randomised controlled studyThe Lancet Neurology, 2007
- Genetic heterogeneity in Niemann-Pick C disease: a study using somatic cell hybridization and linkage analysis.1996